- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04938791
Fatigue and Kinematics During Isometric Activity of the Upper Limbs in Young and Older Adults
Relationship Between Perceive Effort, Physiological and Kinematic Changes During Upper Limbs Isometric Activity and Its Relationship With the Socio-demographic Characteristics
Aperçu de l'étude
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Lisboa, Le Portugal, 1300-125
- Escola Superior de Saúde da Cruz Vermelha Portuguesa - Lisboa
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Healthy
- Minimum age of 18 years;
Exclusion Criteria:
- Unable to provide written consent
- History of heart, cardiovascular and / or respiratory disease,
- Known untreated hypertension, cardiomyopathy, or exercise intolerance
- Presence of cognitive or neurological disorders
- Neuromuscular or orthopaedic disorder that limits the movement of the upper limb to 90° flexion or the maintenance of that position
- BMI ≥ 40
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Isometric activity
All participants will be included in this arm
|
Participants will do elevation of upper limbs and mantain a 90º degree flexion position in an unsupported way.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from Baseline in perceived effort on the Borg category-ratio 10-point scale (CR 10)
Délai: From baseline to end of activity, up to 15 minutes
|
The perceived effort will be measured with Borg CR 10 scale.
Possible scores range from 0 (no exertion at all) to 10 (extremely strong).
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in heart rate
Délai: From baseline to end of activity, up to 15 minutes
|
Heart rate (heart beatings per minute) measured before and during activity to track cardiovascular changes during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in respiratory rate
Délai: From baseline to end of activity, up to 15 minutes
|
Respiratory rate (respiratory cycles per minute) measured before and during activity to track changes in respiratory function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in heart rate variability (HRV)
Délai: From baseline to end of activity, up to 15 minutes
|
Interval (in milliseconds) between consecutive heartbeats measured before and during activity to track changes in autonomic function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in electrodermal activity (EDA)
Délai: From baseline to end of activity, up to 15 minutes
|
Electrical conductance (in microsiemens -µS) between two points of the hand over time measured before and during activity to track changes in autonomic function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential amplitude through surface electromyography (sEMG)
Délai: From baseline to end of activity, up to 15 minutes
|
Muscle action potential amplitude (in millivolts - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential duration through surface electromyography (sEMG)
Délai: From baseline to end of activity, up to 15 minutes
|
Muscle action potential duration (in milliseconds - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential frequency through surface electromyography (sEMG)
Délai: From baseline to end of activity, up to 15 minutes
|
Muscle action potential frequency (in hertz - Hz) of surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in respiratory pattern through inertial motion units (IMU) from baseline and during activity
Délai: From baseline to end of activity, up to 15 minutes
|
Angular range of motion (in degrees) of rib cage and abdominal wall during upper limb activity measured before and during activity to track changes in respiratory pattern during activity
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in upper limb motion angular acceleration through inertial motion units (IMU) system
Délai: From baseline to end of activity, up to 15 minutes
|
Angular acceleration (in m/s^2) of the arm measured before and during activity to track small movements of upper limb during isometric activity
|
From baseline to end of activity, up to 15 minutes
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Health Status
Délai: Before isometric activity
|
Health Status will be measured with Medical Outcomes Study (MOS) Short Form Health Survey 36 Item version 2 which measure health status of populations and individuals.
Possible scores range from 0 0 (worst health status) to 100 (best health status).
|
Before isometric activity
|
|
Physical activity level
Délai: Before isometric activity
|
Physical activity level will be measured using European Prospective Investigation into Cancer and Nutrition Physical Activity Questionnaire (EPIC-PAQ) that allows to estimate energy expenditure through self-report assessment of the intensity and average duration (per day, week and month) of physical activity performed by the participants in three distinct dimensions (professional, domestic and leisure). Participants are classified as ACTIVE if they perform: at least 150 minutes per week of moderate physical activity; OR at least 75 minutes per week of vigorous physical activity; OR at least 150 minutes per week of a combination of moderate-intensity activity. If they don't present any of the conditions described, they will be categorized as SEDENTARY. |
Before isometric activity
|
Collaborateurs et enquêteurs
Les enquêteurs
- Directeur d'études: Daniel López López, PhD, Universidade da Coruña
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- ESSCVP_FIS01/2021
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .